Skip to main content
. 2019 Jul 19;5:120. doi: 10.1038/s41420-019-0200-8

Fig. 1. 14-3-3η induced/maintained CSCs properties and sorafenib resistance.

Fig. 1

a qPCR in triplicate and IB analysis of the expressions of 14-3-3η mRNA (top) and protein (bottom) in HuH7 and HuH7SR cells. b HuH7SR cells were transfected by scrambled or 14-3-3η siRNA (14-3-3η KD), while HuH7 cells were transfected by scrambled or 14-3-3η plasmid (14-3-3η OE), after then, they were treated with sorafenib. Cell viabilities were analyzed in triplicate by CCK-8 solution. c qPCR analysis in triplicate of the expressions of CD133 and EpCAM mRNAs in HuH7 and HuH7SR cells. d HuH7SR cells were transfected by scrambled or 14-3-3η siRNA, qRT-PCR analysis of the expressions of CD133 and EpCAM mRNAs (left); flow cytometry analysis in triplicate of the ratio of CD133+-EpCAM+ cells (right). e HuH7 cells were transfected by scrambled or 14-3-3η plasmid, qRT-PCR analysis of the expressions of CD133 and EpCAM mRNAs (top); flow cytometry analysis in triplicate of the ratio of SP cells (bottom)